Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc.verified

VIRX

Price:

$0.00978

Market Cap:

$388.70K

Viracta Therapeutics, Inc. operates as a precision oncology firm, specializing in the development of therapeutic agents aimed at treating cancers linked to viral infections. The company's leading drug candidate, Nana-val (a combination of nanatinostat and valganciclovir), is currently advancing through multiple clinical trials. It is in Phase II development for Epstein-Barr virus-positive (EBV+) lymphoma. Furthermore, Nana-val is being evaluated in an open-label Phase 2 basket trial, which targets various forms of relapsed/refractory EBV+ lymphoma, and an open-label Phase 1b/2 trial for EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Beyond its flagship pro...[Read more]

Industry

Biotechnology

IPO Date

2005-09-27

Stock Exchange

OTC

Ticker

VIRX

The ROE as of June 2026 (TTM) for Viracta Therapeutics, Inc. (VIRX) is -128.57%

According to Viracta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -128.57%. This represents a change of 40.45% compared to the average of -91.55% of the last 4 quarters.

Viracta Therapeutics, Inc. (VIRX) Historical ROE (quarterly & annually)

How has VIRX ROE performed in the past?

The mean historical ROE of Viracta Therapeutics, Inc. over the last ten years is -208.84%. The current -128.57% ROE has changed -38.43% with respect to the historical average. Over the past ten years (40 quarters), VIRX's ROE was at its highest in in the September 2024 quarter at 159.48%. The ROE was at its lowest in in the September 2016 quarter at -426.37%.

Quarterly (TTM)
Annual

Average

-208.84%

Median

-172.72%

Minimum

-666.54%

Maximum

41.56%

Viracta Therapeutics, Inc. (VIRX) ROE by Quarter and Year

Discovering the peaks and valleys of Viracta Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 304.99%

Maximum Annual ROE = 41.56%

Minimum Annual Increase = -617.79%

Minimum Annual ROE = -666.54%

Quarterly (TTM)
Annual
YearROEChange
2023-278.72%242.15%
2022-81.46%-62.14%
2021-215.17%-617.79%
202041.56%-149.06%
2019-84.70%-87.29%
2018-666.54%304.99%
2017-164.58%-9.00%
2016-180.86%35.08%
2015-133.89%-58.68%
2014-324.02%-153.41%

Viracta Therapeutics, Inc. (VIRX) Average ROE

How has VIRX ROE performed in the past?

The current ROE of Viracta Therapeutics, Inc. (VIRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-191.78%

5-year avg

-123.70%

10-year avg

-208.84%

Viracta Therapeutics, Inc. (VIRX) ROE vs. Peers

How is VIRX’s ROE compared to its peers?

Viracta Therapeutics, Inc.’s ROE is less than RespireRx Pharmaceuticals Inc. (19.21%), less than THC Farmaceuticals, Inc. (-0.33%), less than DH Enchantment Inc. (17.28%), greater than Innovation Pharmaceuticals Inc. (-93.60%), less than Regen BioPharma, Inc. (11.91%), less than CuraScientific Corp (7.59%), less than Actavia Life Sciences, Inc. (243.82%), greater than Levitee Labs Inc. (-258.68%), greater than Wesana Health Holdings Inc. (-506.80%), less than Paradigm Medical Industries, Inc. (19.31%),

Build a custom stock screener for Viracta Therapeutics, Inc. (VIRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viracta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viracta Therapeutics, Inc. (VIRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viracta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Viracta Therapeutics, Inc.'s ROE?

How is the ROE calculated for Viracta Therapeutics, Inc. (VIRX)?

What is the highest ROE for Viracta Therapeutics, Inc. (VIRX)?

What is the 3-year average ROE for Viracta Therapeutics, Inc. (VIRX)?

What is the 5-year average ROE for Viracta Therapeutics, Inc. (VIRX)?

How does the current ROE for Viracta Therapeutics, Inc. (VIRX) compare to its historical average?